NEW YORK, Oct. 17, 2025 (GLOBE NEWSWIRE) -- Levi & Korsinsky, LLP notifies investors in aTyr Pharma, Inc. ("aTyr" or the "Company") (NASDAQ: ATYR) of a class action securities lawsuit. CLASS ...
Affinity Education Group on Tuesday confirmed chief executive Tim Hickey and chief operating officer Nishad Alani had left the organisation. The company owns and operates more than 225 early education ...
Two top executives at one of Australia’s largest childcare providers have quit following recent industry scandals – including the arrest of a former employee. Affinity Education Group on Tuesday ...
NEOSHO, Mo. — The Newton County Historical Society and Neosho Arts Council will present a talk Saturday by historian and author Jeremy Amick detailing the story of Camp Crowder. “The Legacy of Camp ...
SEATTLE — A psychology lecture at the University of Washington erupted into turmoil on Wednesday when a man barged into one of the campus’s largest classrooms, raising a Nazi salute and shouting ...
Children and adolescents are two times more likely to develop long COVID after a second infection, a study found. The study, published Sept. 30 in Lancet Infectious Diseases, used data from the ...
All right. So I will do a quick intro and then we can get going. So thank you all for being here today. It's wonderful to have Royalty Pharma here with us. We are very, very privileged to have you ...
Trust in pharma has always been fragile, and the rise of misinformation has made it even more precarious. In this episode of "The Top Line," recorded at Fierce Pharma Week in Philadelphia, Freda Lewis ...
Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence. Royalty Pharma ( (RPRX)) has issued an ...
British Big Pharma GSK is welcoming President Donald Trump to the U.K. with a hefty gift: a five-year, $30 billion planned investment in U.S. R&D and manufacturing. The funds are set to be spread ...
The U.K.-based AstraZeneca Plc (NASDAQ:AZN) paused a planned 200 million pounds ($271.26 million) investment in its Cambridge research site. AstraZeneca spokesperson told Reuters the company regularly ...
Sanofi has become the latest Big Pharma to freeze R&D investment decisions in the U.K., while Roche confirmed it is staying put—for now. The news that Sanofi won’t consider “any substantial investment ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback